The benefits of bilateral prophylactic mastectomy are probably greater if performed starting from the age of 30 (up to the age of 30, the cumulative risk of BC for BRCA1/BRCA2 PGVs is only 4%); however, over 55 years of age, the evidence of benefit is weak. Here, BRCA1 is linked to breast cancer.